Rare
lephants
Screener
Toggle theme
B
BeOne Medicines AG
BEIGF
·
Healthcare, Drug Manufacturers - General
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2017
Total Cash from Operations:
$2.25B
Line Item
Value
% of Total
Capital Expenditures
$185.8M
8.3%
Other Investing
$90.3M
4.0%
Net Cash Flow
$1.97B
87.7%
Download CSV